Angiogenetic axis angiopoietins/Tie2 and VEGF in familial breast cancer

K. Danza, B. Pilato, R. Lacalamita, T. Addati, F. Giotta, A. Bruno, A. Paradiso, S. Tommasi

Research output: Contribution to journalArticlepeer-review


Angiogenesis leads to the formation of blood vessels from pre-existing ones, allowing tumor growth. Vascular endothelial growth factor (VEGF) and Angiopoietins (Ang-1, Ang-2) have a pivotal role in tumor angiogenesis but few data regarding their role in hereditary breast cancer are available. The aim of the present study was to analyze Ang-1, Ang-2, tyrosine-protein kinase receptor Tie2 and VEGF expression and their correlation in a cohort of familial and sporadic breast cancers in order to verify whether the presence of germline mutations in BRCA may have a role in tumor microenvironment regulation. Tumor samples from a cohort of 41 patients with a first diagnosis and a family history of breast cancer and 19 patients with sporadic breast cancers were enrolled. The expression of Tie2, Ang-1, Ang-2 and VEGF were analyzed by quantitative real-time PCR. Patients harboring BRCA mutations had higher levels of Ang-1 (P=0.05), Ang-2 (P=0.02) and VEGF (P=0.04) mRNA compared with those without BRCA mutations (BRCAX). The same was observed in triple-negative breast cancer (TNBC). Moreover, a positive correlation between Ang-2 and VEGF was found in both the familial breast cancer group (BRCA carriers: r=0.83; P

Original languageEnglish
Pages (from-to)824-830
Number of pages7
JournalEuropean Journal of Human Genetics
Issue number8
Publication statusPublished - Aug 2013


  • Ang-1
  • Ang-2
  • Angiogenesis
  • BRCA1
  • VEGF

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics


Dive into the research topics of 'Angiogenetic axis angiopoietins/Tie2 and VEGF in familial breast cancer'. Together they form a unique fingerprint.

Cite this